We are looking forward to the BSGCT (British Society for Gene & Cell Therapy) Annual Conference 2026 in Newcastle, United Kingdom, on 17–18 April 2026.

This leading UK event brings together scientists, clinicians, and industry innovators to explore the latest breakthroughs in gene and & cell therapy, —from translational research to early‑phase clinical development and emerging therapeutic platforms.

Representing Richmond Pharmacology:

  • Stephen Wilkinson, Business Development Manager

Our Focus at the Conference

  • Advances in gene and & cell therapy development
  • Translational pathways from preclinical findings to first‑in‑human studies
  • Safety and regulatory considerations for next‑generation therapies
  • Biomarker‑driven approaches to early‑phase trials
  • Collaboration between academic groups, biotech innovators, and clinical researchers

Connect With Us

If you are attending the BSGCT Annual Conference 2026 and would like to explore collaboration or development opportunities:

📧 fasteranswers@richmondpharmacology.com

Find out more here: Annual Conference - BSGCT

Latest news

Richmond Pharmacology Appoints Dr Daniel Chapple as Commercial Director

July 13, 2026
Richmond Pharmacology, the London-based contract research organisation and global leader in early phase clinical trials, announces the appointment of Dr Daniel Chapple PhD FCIM as Commercial Director.
Read more

Upcoming Event

ESC Congress 2026

28 - 31 August 2026
Richmond Pharmacology is pleased to attend the ESC Congress 2026 in Munich, Germany, on 28 - 31 August 2026.
View event